STZ disrupts insulin signaling homeostasis in the brain, leading to reduced glucose and oxygen consumption [148], according to the finding that sporadic AD is an insulin-resistant brain condition with a decrease in glucose/energy metabolism in the brain but without a systemic diabetic state [147,149]. Here, INS is linked to Alzheimer disease.